A Study to Evaluate the Safety and Tolerability of Multiple Dose of STSP-0902 in Healthy Subjects
Status:
RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1b, randomized, double-blind, placebo-controlled, multiple ascending dose (MAD) study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of STSP-0902